News
Penn Medicine Reports 30% Drop in Breast Cancer Risk with Ozempic and Wegovy
Penn Medicine researchers report a 30% lower breast cancer risk in women using Ozempic and Wegovy, based on a study of 111,646 patients. Findings suggest GLP-1 drugs may play a role in cancer prevention, though experts stress results are observational.
→
Move Over, Ozempic: Scientists Unveiled a New Diabetes Pill That Burns Fat Without Killing Your Appetite — And It Could Be a Breakthrough for Millions of Americans
Researchers at Karolinska Institutet published a study showing a new oral compound activates muscle metabolism to lower blood sugar and torch fat — without nausea, muscle loss, or the side effects plaguing GLP-1 drugs.
→
The Forgotten Organ Hiding in Your Chest May Hold the Key to Living Longer — And AI Just Proved It
A Harvard-affiliated research team used artificial intelligence to analyze CT scans from tens of thousands of Americans — and discovered that a small organ most doctors ignored after your teens could predict when you'll die.
→
